Edwin Ofori Atta on Permissive Hypertension For Ischemic Stroke
Edwin Ofori Atta, Head Of Pharmacy at Kumasi Hospital, shared on LinkedIn:
”Permissive Hypertension For Ischemic Stroke
In 2026, permissive hypertension remains a standard temporary management strategy for acute ischemic stroke.
It involves intentionally allowing a patient’s blood pressure (BP) to remain elevated to ensure adequate blood flow to the ischemic penumbra—the salvageable brain tissue surrounding the core area of the stroke.
It’s purposely done to maximize cerebral perfusion and promote collateral circulation when the brain’s natural autoregulation of blood flow is impaired.
It’s typically maintained for the first 24hrs to 48hrs following stroke onset.
It’s Primarily candidates are patients with acute ischemic stroke who are not candidates for immediate reperfusion therapies (like “clot-busting” drugs) or those whose BP is high but below dangerous thresholds (<220/120 mmHg)”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis